• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜神经节细胞衰老和青光眼损伤的机制。

Mechanisms of retinal ganglion cell injury in aging and glaucoma.

机构信息

Centre for Eye Research Australia, Department of Ophthalmology, University of Melbourne, Royal Victorian Eye and Ear Hospital, East Melbourne, Vic., Australia.

出版信息

Ophthalmic Res. 2010;44(3):173-8. doi: 10.1159/000316478. Epub 2010 Sep 9.

DOI:10.1159/000316478
PMID:20829641
Abstract

Aging is the greatest risk factor for glaucoma, implying that intrinsic age-related changes to retinal ganglion cells, their supporting tissue or both make retinal ganglion cells susceptible to injury. Changes to the ocular vasculature, connective tissue of the optic nerve head and mitochondria, which have been documented with advancing age and shown to be exacerbated in glaucoma, may predispose to glaucomatous injury. When considering such age-related changes, it is difficult to separate pathological change from physiological change, and cause from consequence. The insults that predispose aged retinal ganglion cells to injury are likely to be varied and multiple; therefore, it may be more relevant to identify and treat common mechanisms that predispose to retinal ganglion cell failure and/or death. We suggest that mitochondrial dysfunction, as either a cause or consequence of injury, renders retinal ganglion cells sensitive to degeneration. Therapeutic approaches that target mitochondria and promote energy production may provide a general means of protecting aged retinal ganglion cells from degeneration, regardless of the etiology.

摘要

衰老是青光眼的最大风险因素,这意味着视网膜神经节细胞及其支持组织或两者的内在年龄相关变化使视网膜神经节细胞容易受到损伤。随着年龄的增长而发生的眼部血管、视神经头部结缔组织和线粒体的变化,以及在青光眼患者中加剧的变化,可能会导致青光眼损伤。在考虑这些与年龄相关的变化时,很难将病理性改变与生理性改变以及病因与后果区分开来。使衰老的视网膜神经节细胞容易受到损伤的损伤可能是多种多样的;因此,识别和治疗易导致视网膜神经节细胞衰竭和/或死亡的常见机制可能更为相关。我们认为,线粒体功能障碍无论是损伤的原因还是结果,都会使视网膜神经节细胞容易发生变性。针对线粒体并促进能量产生的治疗方法可能为保护衰老的视网膜神经节细胞免受变性提供一种通用手段,而与病因无关。

相似文献

1
Mechanisms of retinal ganglion cell injury in aging and glaucoma.视网膜神经节细胞衰老和青光眼损伤的机制。
Ophthalmic Res. 2010;44(3):173-8. doi: 10.1159/000316478. Epub 2010 Sep 9.
2
Mitochondrial dysfunction and glaucoma.线粒体功能障碍与青光眼
J Glaucoma. 2009 Feb;18(2):93-100. doi: 10.1097/IJG.0b013e318181284f.
3
Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria.青光眼节细胞“死亡”的发病机制与神经保护:聚焦于节细胞轴突线粒体
Prog Brain Res. 2008;173:339-52. doi: 10.1016/S0079-6123(08)01124-2.
4
[Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part II].[青光眼视网膜神经节细胞死亡——机制与潜在治疗。第二部分]
Klin Oczna. 2007;109(7-9):353-5.
5
Role of mitochondria in the pathogenesis and treatment of glaucoma.线粒体在青光眼发病机制和治疗中的作用。
Chin Med J (Engl). 2013 Nov;126(22):4358-65.
6
Changes of osteopontin in the aqueous humor of the DBA2/J glaucoma model correlated with optic nerve and RGC degenerations.DBA2/J 青光眼模型房水中骨桥蛋白的变化与视神经和 RGC 变性相关。
Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5759-67. doi: 10.1167/iovs.10-5558. Epub 2010 Jun 23.
7
Optic neuropathies--importance of spatial distribution of mitochondria as well as function.视神经病变——线粒体空间分布及功能的重要性。
Med Hypotheses. 2005;65(6):1038-42. doi: 10.1016/j.mehy.2004.10.021. Epub 2005 Aug 10.
8
Mitochondria: Their role in ganglion cell death and survival in primary open angle glaucoma.线粒体:在原发性开角型青光眼中对神经节细胞死亡和存活的作用。
Exp Eye Res. 2010 Jun;90(6):750-7. doi: 10.1016/j.exer.2010.03.008. Epub 2010 Mar 30.
9
Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies.青光眼中线粒体功能障碍与新兴的生物能量治疗策略
Exp Eye Res. 2011 Aug;93(2):204-12. doi: 10.1016/j.exer.2010.07.015. Epub 2010 Aug 4.
10
Maintenance of retinal ganglion cell mitochondrial functions as a neuroprotective strategy in glaucoma.维持视网膜神经节细胞线粒体功能作为青光眼的神经保护策略。
Curr Opin Pharmacol. 2013 Feb;13(1):16-22. doi: 10.1016/j.coph.2012.09.002. Epub 2012 Sep 20.

引用本文的文献

1
Protein misfolding and mitochondrial dysfunction in glaucoma.青光眼患者的蛋白质错误折叠与线粒体功能障碍
Front Cell Dev Biol. 2025 Apr 25;13:1595121. doi: 10.3389/fcell.2025.1595121. eCollection 2025.
2
AAV-NDI1 Therapy Provides Significant Benefit to Murine and Cellular Models of Glaucoma.AAV-NDI1 疗法为青光眼的小鼠和细胞模型提供显著益处。
Int J Mol Sci. 2024 Aug 15;25(16):8876. doi: 10.3390/ijms25168876.
3
Evaluating the impact of caloric restriction, body mass index and exercise on primary open-angle glaucoma: A review.
评估热量限制、体重指数和运动对原发性开角型青光眼的影响:一项综述。
Eur J Ophthalmol. 2025 Mar;35(2):429-440. doi: 10.1177/11206721241274445. Epub 2024 Aug 22.
4
Association between dietary calcium, potassium, and magnesium consumption and glaucoma.饮食钙、钾和镁的摄入与青光眼的关系。
PLoS One. 2023 Oct 18;18(10):e0292883. doi: 10.1371/journal.pone.0292883. eCollection 2023.
5
Aging, Cellular Senescence, and Glaucoma.衰老、细胞衰老与青光眼。
Aging Dis. 2024 Apr 1;15(2):546-564. doi: 10.14336/AD.2023.0630-1.
6
The Role of Mitophagy in Glaucomatous Neurodegeneration.自噬在青光眼神经退行性变中的作用。
Cells. 2023 Jul 30;12(15):1969. doi: 10.3390/cells12151969.
7
Deficiency of the RNA-binding protein ELAVL1/HuR leads to the failure of endogenous and exogenous neuroprotection of retinal ganglion cells.RNA结合蛋白ELAVL1/HuR的缺乏导致视网膜神经节细胞内源性和外源性神经保护作用失效。
Front Cell Neurosci. 2023 Feb 17;17:1131356. doi: 10.3389/fncel.2023.1131356. eCollection 2023.
8
Electrically-evoked responses for retinal prostheses are differentially altered depending on ganglion cell types in outer retinal neurodegeneration caused by gene mutation.视网膜假体的电诱发反应在由基因突变引起的外视网膜神经变性中,会根据神经节细胞类型而发生不同程度的改变。
Front Cell Neurosci. 2023 Feb 6;17:1115703. doi: 10.3389/fncel.2023.1115703. eCollection 2023.
9
Calcium-Signalling in Human Glaucoma Lamina Cribrosa Myofibroblasts.人青光眼神经节细胞层肌成纤维细胞中的钙信号传导。
Int J Mol Sci. 2023 Jan 9;24(2):1287. doi: 10.3390/ijms24021287.
10
Clinical Tear Fluid Proteomics-A Novel Tool in Glaucoma Research.临床泪液蛋白质组学——青光眼研究的新工具。
Int J Mol Sci. 2022 Jul 23;23(15):8136. doi: 10.3390/ijms23158136.